Jason S. Slakter

16.4k total citations · 5 hit papers
133 papers, 9.0k citations indexed

About

Jason S. Slakter is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Jason S. Slakter has authored 133 papers receiving a total of 9.0k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Ophthalmology, 73 papers in Radiology, Nuclear Medicine and Imaging and 13 papers in Molecular Biology. Recurrent topics in Jason S. Slakter's work include Retinal Diseases and Treatments (99 papers), Retinal and Optic Conditions (60 papers) and Retinal Imaging and Analysis (55 papers). Jason S. Slakter is often cited by papers focused on Retinal Diseases and Treatments (99 papers), Retinal and Optic Conditions (60 papers) and Retinal Imaging and Analysis (55 papers). Jason S. Slakter collaborates with scholars based in United States, United Kingdom and Italy. Jason S. Slakter's co-authors include Lawrence A. Yannuzzi, John A. Sorenson, Richard F. Spaide, David R. Guyer, Dennis A. Orlock, K. Bailey Freund, Yale L. Fisher, James M. Klancnik, Michael J. Cooney and Catherine Meyerle and has published in prestigious journals such as Ophthalmology, American Journal of Ophthalmology and Investigative Ophthalmology & Visual Science.

In The Last Decade

Jason S. Slakter

130 papers receiving 8.6k citations

Hit Papers

RETINAL ANGIOMATOUS PROLIFERATION IN AGE-RELATED MACULAR ... 1994 2026 2004 2015 2001 2006 1994 1995 2012 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. RETINAL ANGIOMATOUS PROLIFERATION IN AGE-RELATED MACULAR DEGENERATION
    2001 506 citations Lawrence A. Yannuzzi, Jason S. Slakter et al. Retina profile →
  2. INTRAVITREAL BEVACIZUMAB TREATMENT OF CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION
    2006 497 citations Richard F. Spaide, James M. Klancnik et al. Retina profile →
  3. Adverse Reactions due to Indocyanine Green
    1994 488 citations Lawrence A. Yannuzzi, David R. Guyer et al. Ophthalmology profile →
  4. INDOCYANINE GREEN VIDEOANGIOGRAPHY OF IDIOPATHIC POLYPOIDAL CHOROIDAL VASCULOPATHY
    1995 482 citations Richard F. Spaide, Lawrence A. Yannuzzi et al. Retina profile →
  5. RETINAL ANGIOMATOUS PROLIFERATION IN AGE–RELATED MACULAR DEGENERATION
    2012 336 citations Lawrence A. Yannuzzi, Jason S. Slakter et al. Retina profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jason S. Slakter United States 48 8.1k 5.3k 1.1k 436 383 133 9.0k
John A. Sorenson United States 42 8.4k 1.0× 5.3k 1.0× 771 0.7× 480 1.1× 355 0.9× 92 9.2k
Carl D. Regillo United States 45 6.9k 0.8× 5.5k 1.0× 1.7k 1.5× 585 1.3× 168 0.4× 226 8.3k
David Sarraf United States 45 6.3k 0.8× 4.3k 0.8× 815 0.8× 733 1.7× 343 0.9× 259 7.0k
Edoardo Midena Italy 41 5.6k 0.7× 4.0k 0.8× 1.0k 1.0× 388 0.9× 164 0.4× 267 6.6k
Michael J. Cooney United States 24 3.3k 0.4× 2.3k 0.4× 442 0.4× 292 0.7× 308 0.8× 41 4.0k
José Garcia-Arumı́ Spain 39 3.9k 0.5× 2.8k 0.5× 881 0.8× 545 1.3× 86 0.2× 171 4.6k
Dante J. Pieramici United States 35 6.2k 0.8× 4.7k 0.9× 959 0.9× 601 1.4× 86 0.2× 103 6.8k
Robert Y. Kim United States 24 7.0k 0.9× 5.4k 1.0× 1.6k 1.5× 102 0.2× 114 0.3× 78 8.9k
Stephan Michels Switzerland 34 4.6k 0.6× 3.1k 0.6× 663 0.6× 151 0.3× 538 1.4× 121 5.1k
Murray C. Killingsworth Australia 30 2.6k 0.3× 1.7k 0.3× 1.4k 1.3× 175 0.4× 147 0.4× 94 4.2k

Countries citing papers authored by Jason S. Slakter

Since Specialization
Citations

This map shows the geographic impact of Jason S. Slakter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason S. Slakter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason S. Slakter more than expected).

Fields of papers citing papers by Jason S. Slakter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason S. Slakter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason S. Slakter. The network helps show where Jason S. Slakter may publish in the future.

Co-authorship network of co-authors of Jason S. Slakter

This figure shows the co-authorship network connecting the top 25 collaborators of Jason S. Slakter. A scholar is included among the top collaborators of Jason S. Slakter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason S. Slakter. Jason S. Slakter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jackson, Timothy L., Jason S. Slakter, Marc Buyse, et al.. (2023). A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration. Ophthalmology. 130(6). 588–597. 32 indexed citations
2.
Heier, Jeffrey S., Allen C. Ho, Michael Samuel, et al.. (2019). Safety and Efficacy of Subretinally Administered Palucorcel for Geographic Atrophy of Age-Related Macular Degeneration. Ophthalmology Retina. 4(4). 384–393. 29 indexed citations
3.
Brown, David M., et al.. (2016). CNV lesion characteristics as a predictor of visual outcome in wet AMD patients receiving combination therapy of intravitreal anti-VEGF therapy and topical Squalamine lactate ophthalmic solution.. Investigative Ophthalmology & Visual Science. 57(12). 4419–4419. 2 indexed citations
4.
Lanzetta, Paolo, et al.. (2014). Characteristics Associated With Suboptimal Response in Patients Treated With Anti-VEGF Therapy for Wet Age-Related Macular Degeneration (wAMD). Investigative Ophthalmology & Visual Science. 55(13). 1312–1312.
5.
Slakter, Jason S., et al.. (2012). Clinical Features Of Unilateral Hemorrhagic Retinopathy: A New Retinal Entity?. Investigative Ophthalmology & Visual Science. 53(14). 5199–5199. 1 indexed citations
6.
Fung, Adrian T., Nishant Kumar, Sushma K Vance, et al.. (2012). Pilot Study to EvaLuate the Role of High-dose RAnbizumab (2.0mg) in the Management of AMD in Patients with PerSistent/RecurrenT Macular Fluid Less than 30 days Following Treatment with Intravitreal Anti-VEGF Therapy (the LAST Study). Investigative Ophthalmology & Visual Science. 53(14). 2033–2033. 1 indexed citations
7.
8.
Sternberg, Paul W., et al.. (2010). Topical OT-551 for Treating Geographic Atrophy: Phase II Results. Investigative Ophthalmology & Visual Science. 51(13). 6416–6416. 6 indexed citations
9.
Slakter, Jason S., et al.. (2009). A Phase 2, Randomized, Controlled Dose-and Interval-Ranging Study of Intravitreal VEGF Trap-Eye in Patients With Neovascular Age-Related Macular Degeneration: Optical Coherence Tomography (OCT) and Fluorescein Angiography (FA) Outcomes at 1 Year. Investigative Ophthalmology & Visual Science. 50(13). 1890–1890. 2 indexed citations
10.
Kaushal, S., F Grossi, Cedric Francois, & Jason S. Slakter. (2009). Complement C3 inhibitor POT-4: Clinical Safety of Intravitreal Administration. Investigative Ophthalmology & Visual Science. 50(13). 5010–5010. 12 indexed citations
11.
Vogel, Roger, et al.. (2009). A Phase II, Double-Masked, Placebo-Controlled, Dose-Comparison Study of the Safety and Efficacy of Fenretinide in the Treatment of Geographic Atrophy in Subjects with Age-Related Macular Degeneration: Baseline Lesion Size, Characteristics, and Preliminary Progression Data. Investigative Ophthalmology & Visual Science. 50(13). 4919–4919. 3 indexed citations
12.
Slakter, Jason S.. (2007). SUMMIT: Combination Therapy With Verteporfin PDT and Ranibizumab for Subfoveal Choroidal Neovascularization Due to AMD. Investigative Ophthalmology & Visual Science. 48(13). 1817–1817. 6 indexed citations
13.
Eandi, Chiara M., Michael D. Ober, K. Bailey Freund, Jason S. Slakter, & Lawrence A. Yannuzzi. (2007). SELECTIVE PHOTODYNAMIC THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH POLYPOIDAL CHOROIDAL NEOVASCULARIZATION. Retina. 27(7). 825–831. 59 indexed citations
14.
Slakter, Jason S., Janice A. Jerdan, Frances Kane, et al.. (2005). Baseline Characteristics of a Phase 3 Clinical Study of Anecortave Acetate 15 mg in Patients With Exudative Age–Related Macular Degeneration (AMD). Investigative Ophthalmology & Visual Science. 46(13). 1374–1374. 1 indexed citations
15.
Slakter, Jason S., John A. Sorenson, Richard F. Spaide, & K. Bailey Freund. (2004). Evaluation of the safety and efficacy of Anecortave Acetate 15 mg for Depot Suspension and triamcinolone acetate 4mg or a combination of both in patients with exudative age–related macular degeneration (AMD). Investigative Ophthalmology & Visual Science. 45(13). 1927–1927. 2 indexed citations
16.
Slakter, Jason S. & Philip J. Rosenfeld. (2003). Verteporfin With Altered (Delayed) Light in Occult CNV (VALIO) – Results of a Phase II Controlled Clinical Trial. Investigative Ophthalmology & Visual Science. 44(13). 1101–1101. 2 indexed citations
17.
Freund, K. Bailey, Lawrence A. Yannuzzi, Richard F. Spaide, et al.. (2002). THE NATURE OF FOCAL AREAS OF HYPERFLUORESCENCE OR ‘HOT SPOTS’ IMAGED WITH INDOCYANINE GREEN ANGIOGRAPHY. Retina. 22(5). 557–568. 47 indexed citations
18.
Spaide, Richard F., Anita Leys, Peter Stalmans, et al.. (1999). Radiation-associated choroidal neovasculopathy. Ophthalmology. 106(12). 2254–2260. 22 indexed citations
19.
Spaide, Richard F., Dennis A. Orlock, Lawrence A. Yannuzzi, et al.. (1998). Digital subtraction indocyanine green angiography of occult choroidal neovascularization. Ophthalmology. 105(4). 680–688. 11 indexed citations
20.
Spaide, Richard F., Anton Haas, Lawrence A. Yannuzzi, et al.. (1996). INDOCYANINE GREEN VIDEOANGIOGRAPHY OF OLDER PATIENTS WITH CENTRAL SEROUS CHORIORETINOPATHY. Retina. 16(3). 203–213. 344 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John A. Sorenson Breakdown of academic impact, for papers by Carl D. Regillo Breakdown of academic impact, for papers by David Sarraf Breakdown of academic impact, for papers by Edoardo Midena Breakdown of academic impact, for papers by Michael J. Cooney Breakdown of academic impact, for papers by José Garcia-Arumı́ Breakdown of academic impact, for papers by Dante J. Pieramici Breakdown of academic impact, for papers by Robert Y. Kim Breakdown of academic impact, for papers by Stephan Michels Breakdown of academic impact, for papers by Murray C. Killingsworth
Rankless by CCL
2026